If the Lions would rather go young at EDGE, which could make sense considering the value of the position and massive cost of bringing one in, perhaps an addition to the secondary would be beneficial.

CSPC Pharmaceutical Group and AstraZeneca have entered a global collaboration and licensing deal to co develop long acting ...

The NBA trade deadline is February 5, with Milwaukee Bucks forward Giannis Antetokounmpo emerging as the most coveted player available. […] ...